News

The company may repurchase shares in the open market or in privately negotiated transactions. According to the company, the timing and extent of any repurchase will depend upon

This ruling resolves all issues in this case with Mannatech winning on all patent and trademark infringement claims brought against Glycoproducts International (Glycobiotics). The judge also entered a

In its first application the company will be focusing on creating novel monoclonal antibodies (MAbs) against cancer markers (the ‘MAbs Technology’). The acquisition was made pursuant to an

Teva expects to receive Momenta and Sandoz’s Paragraph IV certification notice referring to Teva’s US patents, which cover the chemical composition of Copaxone, pharmaceutical compositions containing it, and

The Opposition Division of the European Patent Office, following a three-day hearing, announced its decision to revoke the European patent exclusively licensed to Alnylam Pharmaceuticals from Cancer Research

Each investment unit consists of a share of common stock, two series of common stock purchase warrants to purchase 0.5 share of common stock respectively. The offering of

Under the terms of the agreement, GlaxoSmithKline (GSK) will receive exclusive worldwide rights to co-develop and co-commercialize almorexant. Actelion will continue to lead the ongoing development program and

The decision followed a planned interim analysis of studies C-02-60 A and B that was performed after 2,546 patients had completed the 24 month time point. In this

Over the last two years Mr Prichard served as CFO of ProMetic BioSciences, its UK division and in addition assumed the role of vice president of corporate development